secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nordicus Partners Corp (NORD)
CIK:        0001011060
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001641172-25-022954
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nordicus Partners furnishes independent valuations for Orocidin and Bio-Convert subsidiaries
--------------------------------------------------------------------------------

- Stanton Park Advisors LLC prepared valuation reports for Orocidin's QR-01 and Bio-Convert's QR-02 as of June 30, 2025.
- The valuations are intended for Board evaluation of fair market value and should not be relied upon for other purposes.
- No specific valuation figures are disclosed in the filing; exhibits are placeholders only.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1011060/000164117225022954/0001641172-25-022954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1011060/000164117225022954/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer